{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:23:48Z","timestamp":1787261028582,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008730","name":"The Norwegian Cancer Society","doi-asserted-by":"publisher","award":["216158"],"award-info":[{"award-number":["216158"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2021081"],"award-info":[{"award-number":["2021081"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010223","name":"Jubilee Clinic Forskningsfond against Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010223","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","award":["SLS-890541"],"award-info":[{"award-number":["SLS-890541"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ctro.2026.101220","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:46:36Z","timestamp":1781801196000},"page":"101220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries"],"prefix":"10.1016","volume":"60","author":[{"given":"Liv Cathrine","family":"Heggeb\u00f8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taran Paulsen","family":"Hellebust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Fredrik","family":"Fj\u00e6ra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Ottestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillevi","family":"Rylander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maziar","family":"Hervani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Egeberg","family":"Evensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Blakstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Sprauten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Magelssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janani","family":"Moorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin M.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Vallhagen","family":"Dahlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Goplen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorunn","family":"Brekke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor-Christian Aase","family":"Johannessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tora S.","family":"Solheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Marienhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5ns","family":"Agrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Kinhult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Alkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludvig","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gubanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zupancic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Strandeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingela","family":"Raunert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Flejmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frida","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ramberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Werlenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Blomstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Brandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctro.2026.101220_bb0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2011.05.073","article-title":"Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting","volume":"100","author":"Weber","year":"2011","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.ctro.2026.101220_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1040-8428(03)00028-3","article-title":"Quality assurance in clinical trials","volume":"47","author":"Ottevanger","year":"2003","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"18","key":"10.1016\/j.ctro.2026.101220_bb0015","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctro.2026.101220_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2019.04.012","article-title":"Impact of deviations in target volume delineation \u2013 time for a new RTQA approach?","volume":"137","author":"Cox","year":"2019","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.ctro.2026.101220_bb0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00066-011-0027-6","article-title":"Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy","volume":"188","author":"Fotina","year":"2012","journal-title":"Strahlenther. Onkol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101220_bb0030","doi-asserted-by":"crossref","first-page":"E617","DOI":"10.1016\/j.ijrobp.2019.06.1148","article-title":"A multi-institutional estimation of Interobserver variability in glioblastoma delineation in the EORTC-1709-BTG \/CCTG CE.8 trial","volume":"105","author":"Kaidar-Person","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctro.2026.101220_bb0035","author":"Gregoire"},{"issue":"17","key":"10.1016\/j.ctro.2026.101220_bb0040","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.ejca.2012.06.002","article-title":"Do results of the EORTC dummy run predict quality of radiotherapy delivered within multicentre clinical trials?","volume":"48","author":"Fairchild","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.ctro.2026.101220_bb0045","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.radonc.2014.04.015","article-title":"Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071\u201324071 prospective study for head and neck cancer","volume":"111","author":"Weber","year":"2014","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.ctro.2026.101220_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070071","article-title":"Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden","volume":"13","author":"Heggeb\u00f8","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.ctro.2026.101220_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110950","article-title":"Recommendations for radiotherapy quality assurance in clinical trials","volume":"209","author":"Nielsen","year":"2025","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.ctro.2026.101220_bb0060","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1016\/S1470-2045(23)00625-3","article-title":"Radiotherapy trial quality assurance processes: a systematic review","volume":"25","author":"Brooks","year":"2024","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101220_bb0065","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.1038\/s41467-022-34257-x","article-title":"Deep learning empowered volume delineation of whole-body organs-at-risk for accelerated radiotherapy","volume":"13","author":"Shi","year":"2022","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.ctro.2026.101220_bb0070","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1002\/mp.15146","article-title":"Automated delineation of head and neck organs at risk using synthetic MRI-aided mask scoring regional convolutional neural network","volume":"48","author":"Dai","year":"2021","journal-title":"Med. Phys."},{"key":"10.1016\/j.ctro.2026.101220_bb0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.radonc.2019.10.019","article-title":"Comparing deep learning-based auto-segmentation of organs at risk and clinical target volumes to expert inter-observer variability in radiotherapy planning","volume":"144","author":"Wong","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101220_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.radonc.2022.10.029","article-title":"Comparison of atlas-based and deep learning methods for organs at risk delineation on head-and-neck CT images using an automated treatment planning system","volume":"177","author":"Costea","year":"2022","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101220_bb0085","article-title":"Feasibility of deep learning-based tumor segmentation for target delineation and response assessment in grade-4 glioma using multi-parametric MRI","volume":"5","author":"Hannisdal","year":"2023","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.ctro.2026.101220_bb0090","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.5114\/pjr.2023.124434","article-title":"Fully automated clinical target volume segmentation for glioblastoma radiotherapy using a deep convolutional neural network","volume":"88","author":"Sadeghi","year":"2023","journal-title":"Pol. J. Radiol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101220_bb0095","article-title":"Deep learning-based postoperative glioblastoma segmentation and extent of resection evaluation: development, external validation, and model comparison","volume":"6","author":"Cepeda","year":"2024","journal-title":"Neuro-oncol Adv"},{"issue":"5","key":"10.1016\/j.ctro.2026.101220_bb0100","article-title":"Review of deep learning based autosegmentation for clinical target volume: current status and future directions","volume":"9","author":"Matoska","year":"2024","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101220_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.radonc.2017.12.013","article-title":"The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology","volume":"128","author":"Eekers","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101220_bb0110","series-title":"Norwegian guidelines for delineation of organs at risk in neuro-oncology","author":"Marienhagen","year":"2020"},{"key":"10.1016\/j.ctro.2026.101220_bb0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.radonc.2021.05.013","article-title":"Update of the EPTN atlas for CT- and MR-based contouring in neuro-oncology","volume":"160","author":"Eekers","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101220_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110594","article-title":"ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma","volume":"202","author":"Baumert","year":"2025","journal-title":"Radiother. Oncol."},{"issue":"7","key":"10.1016\/j.ctro.2026.101220_bb0125","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1002\/mp.12256","article-title":"Use of image registration and fusion algorithms and techniques in radiotherapy: report of the AAPM radiation therapy committee task group no. 132","volume":"44","author":"Brock","year":"2017","journal-title":"Med. Phys."},{"issue":"1","key":"10.1016\/j.ctro.2026.101220_bb0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12880-015-0068-x","article-title":"Metrics for evaluating 3D medical image segmentation: analysis, selection, and tool","volume":"15","author":"Taha","year":"2015","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.ctro.2026.101220_bb0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2018.05.001","article-title":"Radiation dose constraints for organs at risk in neuro-oncology; the European particle therapy network consensus","volume":"128","author":"Lambrecht","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101220_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2026.111595","article-title":"Dose-based evaluation of delineation variation in radiotherapy: a scoping review","volume":"221","author":"van Aalst","year":"2026","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101220_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fonc.2017.00221","article-title":"Challenges for quality assurance of target volume delineation in clinical trials","volume":"7","author":"Chang","year":"2017","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.ctro.2026.101220_bb0150","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.semradonc.2014.06.009","article-title":"Standardization and quality assurance of radiation therapy volumes for adults with high-grade gliomas","volume":"24","author":"Fogh","year":"2014","journal-title":"Semin. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101220_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00066-003-0976-5","article-title":"The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences","volume":"179","author":"Weiss","year":"2003","journal-title":"Strahlentherapie und Onkologie\u202f: Organ der Deutschen Rontgengesellschaft [et al]"},{"issue":"10","key":"10.1016\/j.ctro.2026.101220_bb0160","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3174\/ajnr.A5368","article-title":"Diagnostic accuracy of neuroimaging to delineate diffuse gliomas within the brain: a meta-analysis","volume":"38","author":"Verburg","year":"2017","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/j.ctro.2026.101220_bb0165","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.radonc.2010.03.005","article-title":"Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: first evaluation of quality of radiotherapy planning","volume":"95","author":"Musat","year":"2010","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.ctro.2026.101220_bb0170","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.radonc.2012.04.002","article-title":"Quality assurance in the EORTC 22033\u201326033\/CE5 phase III randomized trial for low grade glioma: the digital individual case review","volume":"103","author":"Fairchild","year":"2012","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101220_bb0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13014-021-01756-y","article-title":"Cranial organs at risk delineation: heterogenous practices in radiotherapy planning","volume":"16","author":"Vogin","year":"2021","journal-title":"Radiat. Oncol."},{"issue":"14","key":"10.1016\/j.ctro.2026.101220_bb0180","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1088\/0031-9155\/56\/14\/021","article-title":"Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: a multi-expert study","volume":"56","author":"Deeley","year":"2011","journal-title":"Phys. Med. Biol."},{"issue":"11","key":"10.1016\/j.ctro.2026.101220_bb0185","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1080\/0284186X.2021.1975813","article-title":"A national study on the inter-observer variability in the delineation of organs at risk in the brain","volume":"60","author":"Lorenzen","year":"2021","journal-title":"Acta Oncol."},{"issue":"Supplement_5","key":"10.1016\/j.ctro.2026.101220_bb0190","doi-asserted-by":"crossref","first-page":"v102","DOI":"10.1093\/neuonc\/noaf201.0414","article-title":"RADT-45. The multicenter soprano study: outcomes of patients with idh-mutated who grade 2 and 3 glioma treated with proton or photon radiotherapy","volume":"27","author":"Nagtegaal","year":"2025","journal-title":"Neuro-oncol"},{"issue":"Supplement_5","key":"10.1016\/j.ctro.2026.101220_bb0195","doi-asserted-by":"crossref","first-page":"v19","DOI":"10.1093\/neuonc\/noae144.055","article-title":"OS05.7.OS05.7.A radiation-induced contrast enhancement after proton therapy in patients with gliomas in the PRO-CNS study","volume":"26","author":"Werlenius","year":"2024","journal-title":"Neuro-oncol"},{"key":"10.1016\/j.ctro.2026.101220_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109674","article-title":"Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma","volume":"184","author":"Jaspers","year":"2023","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101220_bb0205","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2021.12.035","article-title":"Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma - how safe are protons?","volume":"167","author":"Harrabi","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101220_bb0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.radonc.2022.08.025","article-title":"Iatrogenic influence on prognosis of radiation-induced contrast enhancements in patients with glioma WHO 1-3 following photon and proton radiotherapy","volume":"175","author":"Eichkorn","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101220_bb0215","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ctro.2018.01.002","article-title":"Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma","volume":"9","author":"Bronk","year":"2018","journal-title":"Clinical and Translational Radiation Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101220_bb0220","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijrobp.2018.01.099","article-title":"Association of 1p\/19q Codeletion and radiation necrosis in adult cranial gliomas after proton or photon therapy","volume":"101","author":"Acharya","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ctro.2026.101220_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-015-0439-z","article-title":"Evaluation of variability in target volume delineation for newly diagnosed glioblastoma: a multi-institutional study from the Korean radiation oncology group","volume":"10","author":"Wee","year":"2015","journal-title":"Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101220_bb0230","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13014-025-02612-z","article-title":"Dummy run study for outlining and plan quality of intensity-modulated radiotherapy in elderly patients with newly diagnosed glioblastoma: the Japan clinical oncology group study JCOG1910 (AgedGlio-PIII)","volume":"20","author":"Ono","year":"2025","journal-title":"Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101220_bb0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0167-8140(01)00371-1","article-title":"Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging","volume":"60","author":"Weltens","year":"2001","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.ctro.2026.101220_bb0240","doi-asserted-by":"crossref","first-page":"e710","DOI":"10.1016\/j.ijrobp.2020.07.077","article-title":"Inter-observer variation in tumor volume delineation of low grade gliomas, a multi-institutional contouring study","volume":"108","author":"Boer","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctro.2026.101220_bb0245","article-title":"Deep-learning magnetic resonance imaging-based automatic segmentation for organs-at-risk in the brain: accuracy and impact on dose distribution","volume":"27","author":"Turcas","year":"2023","journal-title":"Physics and Imaging in Radiation Oncol"},{"key":"10.1016\/j.ctro.2026.101220_bb0250","doi-asserted-by":"crossref","unstructured":"Buti G, Giovenco M, Yilmaz T, Ajdari A, Bridge CP, Sharp GC, et al. Clinical target volumes for glioma \u2013 Automated delineation to improve neuroanatomic consistency. Physics and Imaging in Radiation Oncol 2025;36:100865. DOI:https:\/\/doi.org\/10.1016\/j.phro.2025.100865.","DOI":"10.1016\/j.phro.2025.100865"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:26:11Z","timestamp":1787257571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"alternative-id":["S2405630826001151"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101220","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101220"}}